FDA recently issued a warning letter to clinical investigator Betty Tuller, PhD, after she purportedly violated several requirements under 21 CFR Part 312 while working at Florida Atlantic University’s Center for Complex Systems and Brain Sciences. According to the...
Please join the Circle City Chapter of Association of Clinical Research Professionals for their upcoming speaking event TOPIC: FDA Form 483’s & FDA Warning Letters Involving Clinical Drug Trials Issued in 2010: What We Can Learn Presented by David Finch, CCRP,...
